Reduced bone mineral density in patients with haemophilia A and B in Northern Greece

Summary

Haemophilia A and B has been associated with increased prevalence of low bone mass (67–86%). The aim of this study was to estimate the prevalence of bone disease in haemophiliacs and its association with potential risk factors. Adult patients with haemophilia A and B followed-up in the Haemophilia Centre of Northern Greece were included. Bone mineral density (BMD) was measured by dual-energy X-ray absorptiometry (DXA) in lumbar spine (LS), femoral neck (FN), total hip (TH) and great trochanter (GT). One-hundred four male patients (aged 45.8 ± 15.1 years) and 50 controls (aged 44.9 ± 12.8 years) were screened. Low BMD was diagnosed in 28 patients (26.9%) and 10 controls (20%) (p=0.0001). Patients had lower BMD in TH (p=0.007), FN (p=0.029) and GT (p=0.008) than controls, without differences in LS. BMD was positively associated with the severity of haemophilia, history of herpes virus C or human immunodeficiency virus and level of physical activity, and negatively with the level of arthropathy. In multiple-regression analysis, only the level of physical activity and 25-hydroxyvitamin D [25(OH)D] significantly predicted BMD. Half of the patients had vitamin D deficiency. In conclusion, our study showed increased prevalence of low BMD in haemophiliacs. The levels of physical activity and 25(OH)D independently predicted low BMD.

Keywords

Haemophilia - osteoporosis - osteopenia - bone mass

• References

• 1 NIH Consensus Development Panel on Osteoporosis. Osteoporosis prevention, diagnosis and therapy. J Am Med Assoc 2001; 285: 785-795.
• 2 Vestergaard P. et al. Increased mortality in patients with a hip fracture-effect of pre-morbid conditions and post-fracture complications. Osteoporos Int 2007; 18: 1583-1593.
• 3 Ebeling P. Osteoporosis in men. N Engl J Med 2008; 358: 1474-1482.
• 4 Gielen E. et al. Osteoporosis in men. Best Pract Res Clin Endocrinol Metab 2011; 25: 321-335.
• 5 Center JR. et al. Mortality after all major types of osteoporotic fracture in men and women: an observational study. Lancet 1999; 353: 878-882.
• 6 Hoots WK. et al. Pathogenesis of haemophilic synovitis: clinical aspects. Haemophilia 2007; 13 (Suppl. 03) 4-9.
• 7 Lafeber F P. et al. Physiopathology of haemophilic arthropathy. Haemophilia 2008; 14 (Suppl. 04) 3-9.
• 8 Ling M. et al. High incidence of ankle arthropathy in mild and moderate haemophilia A. Thromb Haemost 2011; 105: 261-268.
• 9 Forsyth AL. et al. Role of exercise and physical activity on haemophilic arthropathy, fall prevention and osteoporosis. Haemophilia 2011; 17: e870-876.
• 10 Barnes C. et al. Reduced bone density among children with severe hemophilia. Pediatrics 2004; 114: e177-181.
• 11 Tlacuilo-Parra A. et al. Inactivity is a risk factor for low bone mineral density among haemophilic children. Br J Haematol 2008; 140: 562-567.
• 12 Abdelrazik N. et al. Evaluation of bone mineral density in children with hemophilia: Mansoura University children hospital (MUCH) experience, Mansoura, Egypt. Hematology 2007; 12: 431-437.
• 13 Christoforidis A. et al. Bone status of children with hemophilia A assessed with quantitative ultrasound sonography (QUS) and dual energy X-ray absorptiometry (DXA). J Pediatr Hematol Oncol 2010; 32: e259-263.
• 14 Gallacher SJ. et al. Association of severe haemophilia A with osteoporosis: a densitometric and biochemical study. Q J Med 1994; 87: 181-186.
• 15 Mansouritorghabeh H. et al. Are individuals with severe haemophilia A prone to reduced bone density?. Rheumatol Int 2008; 28: 1079-1083.
• 16 Mansouritorghabeh H. et al. Reduced bone density in individuals with severe hemophilia B. Int J Rheum Dis 2009; 12: 125-129.
• 17 Wallny TA. et al. Osteoporosis in haemophilia - an underestimated comorbidity?. Haemophilia 2007; 13: 79-84.
• 18 Nair A P. et al. Osteoporosis in young haemophiliacs from western India. Am J Hematol 2007; 82: 453-457.
• 19 Gerstner G. et al. Prevalence and risk factors associated with decreased bone mineral density in patients with haemophilia. Haemophilia 2009; 15: 559-565.
• 20 Katsarou O. et al. Increased bone resorption is implicated in the pathogenesis of bone loss in hemophiliacs: correlations with hemophilic arthropathy and HIV infection. Ann Hematol. 2009 epub ahead of print.
• 21 Iorio A. et al. Bone mineral density in haemophilia patients. A meta-analysis. Thromb Haemost 2010; 103: 596-603.
• 22 Lederman MM. Haemophilia, human immunodeficiency virus and human immunodeficiency virus pathogenesis. Thromb Haemost 2010; 104: 911-914.
• 23 Kanis JA. et al. FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos Int 2008; 19: 385-397.
• 24 Baim S. et al. Official Positions of the International Society for Clinical Densito-metry and executive summary of the 2007 ISCD Position Development Conference. J Clin Densitom 2008; 11: 75-91.
• 25 Ng WH. et al. Role of imaging in management of hemophilic patients. AJR Am J Roentgenol 2005; 184: 1619-1623.
• 26 Khawaji M. et al. Long-term prophylaxis in severe haemophilia seems to preserve bone mineral density. Haemophilia 2009; 15: 261-266.
• 27 Ghosh K. et al. Fractures of long bones in severe haemophilia. Haemophilia 2007; 13: 337-339.
• 28 Kovacs CS. Hemophilia, low bone mass, and osteopenia/osteoporosis. Transfus Apher Sci 2008; 38: 33-40.
• 29 Moayyeri A. The association between physical activity and osteoporotic fractures: a review of the evidence and implications for future research. Ann Epidemiol 2008; 18: 827-835.
• 30 Welten DC. et al. Weight-bearing activity during youth is a more important factor for peak bone mass than calcium intake. J Bone Miner Res 1994; 9: 1089-1096.
• 31 Bradney M. et al. Moderate exercise during growth in prepubertal boys: changes in bone mass, size, volumetric density, and bone strength: a controlled prospective study. J Bone Miner Res 1998; 13: 1814-1821.
• 32 Indridason SO. et al. Serum osteoprotegerin and its relationship with bone mineral density and markers of bone turnover. Osteoporos Int 2005; 16: 417-423.
• 33 Reid IR. Relationships between fat and bone. Osteoporos Int 2008; 19: 595-606.
• 34 Giouleme OI. et al. Pathogenesis of osteoporosis in liver cirrhosis. Hepatog-astroenterology 2006; 53: 938-943.
• 35 Moschen AR. et al. The RANKL/OPG system and bone mineral density in patients with chronic liver disease. J Hepatol 2005; 43: 973-983.
• 36 Lee J. et al. Ribavirin enhances osteoclast formation through osteoblasts via up-regulation of TRANCE/RANKL. Mol Cell Biochem 2007; 296: 17-24.
• 37 Bonjoch A, et al. Osteoporosis St ud y Grou p. Hig h pre valence of an d prog ression to low bone mineral density in HIV-infected patients: a longitudinal cohort study. AIDS 2010; 24: 2827-2833.
• 38 Brown T T, Qaqish RB. Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review. AIDS 2006; 20: 2165-2174.
• 39 Ofotokun I, Weitzmann MN. HIV and bone metabolism. Discov Med 2011; 11: 385-393.
• 40 Gibellini D. et al. RANKL/OPG/TRAIL plasma levels and bone mass loss evaluation in antiretroviral naive HIV-1-positive men. J Med Virol 2007; 79: 1446-1454.
• 41 Kerr GS. et al. Prevalence of vitamin D insufficiency/deficiency in rheumatoid arthritis and associations with disease severity and activity. J Rheumatol 2011; 38: 53-59.
• 42 Rossini M. et al. Vitamin D deficiency in rheumatoid arthritis: prevalence, determinants and associations with disease activity and disability. Arthritis Res Ther 2010; 12: R216.
• 43 Chlebowski RT. et al. 25-hydroxyvitamin D concentration, vitamin D intake and joint symptoms in postmenopausal women. Maturitas 2011; 68: 73-78.